| Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 StudyNCT06651580 · Los Angeles, California | — | 22 |
| Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialNCT04575935 · Miami, Florida | Phase 3 | 13 |
| Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenNCT00539162 · Miami, Florida | Not applicable | 12 |
| Measuring Surgical Recovery After Radical CystectomyNCT03193970 · San Francisco, California | — | 11 |
| Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast CancerNCT00477100 · Gilbert, Arizona | — | 10 |
| Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)NCT03460769 · Los Angeles, California | — | 10 |
| Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C StudyNCT04739072 · Gilbert, Arizona | — | 10 |
| Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort StudyNCT05287451 · Boston, Massachusetts | Not applicable | 9 |
| Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyNCT02945579 · Gilbert, Arizona | Not applicable | 8 |
| Customized 3D Printed Oral Stents During Head and Neck RadiotherapyNCT04870762 · Phoenix, Arizona | Phase 2 | 7 |
| Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaNCT06053658 · Irvine, California | Phase 2 | 6 |
| PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.NCT06274047 · Gilbert, Arizona | Phase 3 | 6 |
| A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)NCT06708949 · Boston, Massachusetts | Phase 2 | 6 |
| Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic LeukemiaNCT01409161 · Houston, Texas | Phase 2 | 5 |
| Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic MalignanciesNCT03471260 · Boston, Massachusetts | Phase 1/2 | 4 |
| Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast SurgeryNCT04169542 · Conroe, Texas | — | 4 |
| A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and RevumenibNCT06284486 · Baltimore, Maryland | Phase 1/2 | 4 |
| Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialNCT06593431 · Camden, New Jersey | Phase 3 | 4 |
| Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before SurgeryNCT06959511 · Ann Arbor, Michigan | Phase 2 | 4 |
| Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast CancerNCT07076485 · Loveland, Colorado | Phase 2 | 4 |
| Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic SyndromeNCT03383575 · Baltimore, Maryland | Phase 2 | 3 |
| Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of RecurrenceNCT03583710 · Ann Arbor, Michigan | Phase 3 | 3 |
| HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsNCT03911388 · Birmingham, Alabama | Phase 1 | 3 |
| Nodal Radiation Therapy for Sentinel Lymph Node Positive MelanomaNCT04594187 · Jacksonville, Florida | Phase 2 | 3 |
| PCORI-CER-1306-03385 Lung Cancer Screening Decision Aid Development and TestingNCT02282969 · Galveston, Texas | — | 2 |
| Couple-Based Meditation for Metastatic Lung Cancer Patients and Their PartnersNCT02596490 · Houston, Texas | Not applicable | 2 |
| LET Optimized IMPT in Treating Pediatric Patients With EpendymomaNCT03750513 · Boston, Massachusetts | Phase 1 | 2 |
| Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersNCT03968406 · Baltimore, Maryland | Phase 1 | 2 |
| Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping StrategiesNCT04003051 · Fort Worth, Texas | Phase 2 | 2 |
| Natural History of Medullary Thyroid Cancer to Inform Advanced Disease ManagementNCT04216732 · San Francisco, California | — | 2 |
| Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell TransplantNCT04678427 · Dallas, Texas | Not applicable | 2 |
| Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS StudyNCT05019703 · Boston, Massachusetts | Phase 2 | 2 |
| Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction CancersNCT05205343 · Rochester, Minnesota | — | 2 |
| Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in TexasNCT05676450 · Houston, Texas | Not applicable | 2 |
| A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)NCT05834244 · Cleveland, Ohio | Phase 1 | 2 |
| Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyNCT06083844 · New York, New York | Phase 2 | 2 |
| Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer ScreeningNCT06109870 · Austin, Texas | Not applicable | 2 |
| A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesNCT06229912 · New York, New York | Phase 2 | 2 |
| Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaNCT06308588 · The Bronx, New York | Phase 1/2 | 2 |
| A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C MutationsNCT06412198 · Boston, Massachusetts | Phase 1/2 | 2 |
| Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersNCT06434363 · Houston, Texas | Phase 1/2 | 2 |
| A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.NCT06566742 · Miami, Florida | Phase 2 | 2 |
| A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)NCT06616636 · Tampa, Florida | Phase 1 | 2 |
| A Phase I/II Study of IVONESCIMAB in Recurrent GlioblastomaNCT06672575 · Houston, Texas | Phase 1/2 | 2 |
| Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid CarcinomaNCT07218315 · Sarasota, Florida | Not applicable | 2 |
| Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial CancerNCT07382583 · Houston, Texas | — | 2 |
| Cladribine and Rituximab in Treating Patients With Hairy Cell LeukemiaNCT00412594 · Houston, Texas | Phase 2 | 1 |
| Data Collection for Patients With Low Grade Ovarian or Peritoneal TumorsNCT00488878 · Houston, Texas | — | 1 |
| A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative OutcomesNCT00493688 · Houston, Texas | — | 1 |
| Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaNCT00501826 · Houston, Texas | Phase 2 | 1 |
| New Assessment System in Measuring Symptom Distress in Cancer PatientsNCT00505245 · Houston, Texas | — | 1 |
| Psychophysical Studies of Cancer Therapy PainNCT00515060 · Houston, Texas | — | 1 |
| Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT00801489 · Houston, Texas | Phase 2 | 1 |
| Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical TrialNCT00816114 · Houston, Texas | — | 1 |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton TherapyNCT00991094 · Houston, Texas | — | 1 |
| Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing SurgeryNCT01269190 · Houston, Texas | Not applicable | 1 |
| Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"NCT01365169 · Houston, Texas | Not applicable | 1 |
| Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic LeukemiaNCT01371630 · Houston, Texas | Phase 1/2 | 1 |
| Long-Term Follow-Up of Recipient of Gene Transfer ResearchNCT01492036 · Houston, Texas | — | 1 |
| Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)NCT01515527 · Houston, Texas | Phase 2 | 1 |
| Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or NilotinibNCT01746836 · Houston, Texas | Phase 2 | 1 |
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy ProgramNCT01772771 · Houston, Texas | — | 1 |
| Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal CancerNCT02107105 · Houston, Texas | — | 1 |
| Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid LeukemiaNCT02115295 · Houston, Texas | Phase 2 | 1 |
| Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary CancerNCT02361320 · Houston, Texas | Not applicable | 1 |
| PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid LeukemiaNCT02390635 · Houston, Texas | Phase 1 | 1 |
| ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic SyndromeNCT02392572 · Houston, Texas | Phase 1/2 | 1 |
| Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory FailureNCT02464696 · Houston, Texas | Not applicable | 1 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusNCT02479698 · Houston, Texas | Phase 2 | 1 |
| Observational Prospective Research Study In Monoclonal Gammopathies leadINg to MyelomaNCT02726750 · Houston, Texas | — | 1 |
| Personalized NK Cell Therapy in CBTNCT02727803 · Houston, Texas | Phase 2 | 1 |
| Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain TumorsNCT02754544 · Houston, Texas | Not applicable | 1 |
| Molecular Basis for Variations in Hereditary Colorectal Cancer SyndromesNCT02863172 · Houston, Texas | — | 1 |
| Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic LeukemiaNCT02877303 · Houston, Texas | Phase 2 | 1 |
| Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast CancerNCT02918474 · Houston, Texas | Not applicable | 1 |
| Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by SurgeryNCT03007030 · Houston, Texas | Phase 2 | 1 |
| Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerNCT03010150 · Houston, Texas | — | 1 |
| Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid TumorsNCT03039439 · Houston, Texas | — | 1 |
| Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 PatientsNCT03048266 · Houston, Texas | — | 1 |
| Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary MetastasesNCT03093909 · Houston, Texas | Phase 1 | 1 |
| Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal CancerNCT03114462 · Houston, Texas | Phase 1 | 1 |
| Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLLNCT03128879 · Houston, Texas | Phase 2 | 1 |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/LeukemiaNCT03136146 · Houston, Texas | Phase 2 | 1 |
| Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the BodyNCT03145077 · Houston, Texas | Not applicable | 1 |
| Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric CancerNCT03161522 · Houston, Texas | Phase 2 | 1 |
| Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid LeukemiaNCT03214562 · Houston, Texas | Phase 1/2 | 1 |
| Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic LeukemiaNCT03263572 · Houston, Texas | Phase 2 | 1 |
| Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic CancerNCT03295227 · Houston, Texas | Phase 1 | 1 |
| Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis FungoidesNCT03398161 · Houston, Texas | Phase 2 | 1 |
| Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource UtilizationNCT03407469 · Houston, Texas | — | 1 |
| Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT StudyNCT03408353 · Houston, Texas | — | 1 |
| Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung CancerNCT03422302 · Houston, Texas | Not applicable | 1 |
| Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related DiseaseNCT03425526 · Houston, Texas | Phase 1 | 1 |
| Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral MalignanciesNCT03458676 · Houston, Texas | Not applicable | 1 |
| Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural EffusionsNCT03465774 · Houston, Texas | — | 1 |
| Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid LeukemiaNCT03586609 · Houston, Texas | Phase 2 | 1 |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood CancersNCT03589729 · Houston, Texas | Phase 2 | 1 |
| Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal CancerNCT03594630 · Houston, Texas | Early phase 1 | 1 |
| Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTFNCT03604315 · Houston, Texas | Phase 1 | 1 |
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D MutationNCT03608631 · Houston, Texas | Phase 1/2 | 1 |
| Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid LeukemiaNCT03629171 · Houston, Texas | Phase 2 | 1 |
| Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing ChemotherapyNCT03630991 · Houston, Texas | Phase 1 | 1 |
| Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene MutationNCT03683433 · Houston, Texas | Phase 2 | 1 |
| Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain MetastasesNCT03741673 · Houston, Texas | Phase 3 | 1 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With CancerNCT03819296 · Houston, Texas | Phase 1 | 1 |
| Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain TumorsNCT03830151 · Houston, Texas | Phase 1 | 1 |
| Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their CaregiversNCT03892993 · Houston, Texas | Not applicable | 1 |
| CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic LeukemiaNCT03896269 · Houston, Texas | Phase 1 | 1 |
| MSC-DNX-2401 in Treating Patients With Recurrent High-Grade GliomaNCT03896568 · Houston, Texas | Phase 1 | 1 |
| Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or MelanomaNCT03941756 · Houston, Texas | Not applicable | 1 |
| Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their CaregiversNCT03948100 · Houston, Texas | Not applicable | 1 |
| Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryNCT04003038 · Houston, Texas | Not applicable | 1 |
| Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantNCT04022239 · Houston, Texas | Phase 1/2 | 1 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsNCT04038619 · Houston, Texas | Phase 1 | 1 |
| Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT04047641 · Houston, Texas | Phase 1/2 | 1 |
| Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerNCT04090567 · Houston, Texas | Phase 2 | 1 |
| Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative NeoplasmNCT04140487 · Houston, Texas | Phase 1/2 | 1 |
| High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer SurvivorsNCT04151082 · Houston, Texas | Phase 1/2 | 1 |
| Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNCT04169737 · Houston, Texas | Phase 2 | 1 |
| Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by SurgeryNCT04169763 · Houston, Texas | Phase 1 | 1 |
| Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaNCT04199026 · Houston, Texas | Not applicable | 1 |
| Venetoclax, SL-401, and Chemotherapy for the Treatment of Blastic Plasmacytoid Dendritic Cell NeoplasmNCT04216524 · Houston, Texas | Phase 2 | 1 |
| A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic LeukemiaNCT04239157 · Houston, Texas | Phase 2 | 1 |
| Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base TumorsNCT04265430 · Houston, Texas | Phase 4 | 1 |
| MRE Scan for the Assessment of Differences in Tissue Stiffness Between Radiation Necrosis and Recurrent Glioma in Patients With Previously Treated GliomasNCT04373720 · Houston, Texas | Not applicable | 1 |
| Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar CancerNCT04380545 · Houston, Texas | Phase 1/2 | 1 |
| Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 PandemicNCT04474301 · Houston, Texas | — | 1 |
| Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain TumorsNCT04479696 · Houston, Texas | Not applicable | 1 |
| Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center WorkforceNCT04491292 · Houston, Texas | — | 1 |
| CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT04493164 · Houston, Texas | Phase 2 | 1 |
| The Effect of COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients and SurvivorsNCT04551378 · Houston, Texas | — | 1 |
| An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic TherapyNCT04589624 · Houston, Texas | Phase 1 | 1 |
| Educating Smokers About Lung Cancer Screening Using Tobacco QuitlinesNCT04595422 · Houston, Texas | Not applicable | 1 |
| Self-monitoring Focus Groups With Vibrant Lives Pasadena ParticipantsNCT04611087 · Houston, Texas | — | 1 |
| NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerNCT04615013 · Houston, Texas | Phase 1 | 1 |
| Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) GlioblastomasNCT04623931 · Houston, Texas | Phase 2 | 1 |
| Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal CancersNCT04629677 · Houston, Texas | — | 1 |
| The Rise in Robotic Atypical SegmentectomiesNCT04644952 · Houston, Texas | — | 1 |
| Role of Diet on the Microbiome of the Digestive SystemNCT04666727 · Houston, Texas | — | 1 |
| Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME TrialNCT04693377 · Houston, Texas | Not applicable | 1 |
| Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom TrialNCT04693468 · Houston, Texas | Phase 1 | 1 |
| Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDSNCT04708054 · Houston, Texas | Phase 2/3 | 1 |
| Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsNCT04712539 · Houston, Texas | Phase 2 | 1 |
| Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the CervixNCT04723095 · Houston, Texas | — | 1 |
| Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host DiseaseNCT04744116 · Houston, Texas | Early phase 1 | 1 |
| Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsNCT04751396 · Houston, Texas | — | 1 |
| Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid TumorsNCT04771520 · Houston, Texas | Phase 2 | 1 |
| Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade GliomaNCT04771806 · Houston, Texas | — | 1 |
| Decitabine/Cedazuridine and Venetoclax in Combination With Ivosidenib or Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaNCT04774393 · Houston, Texas | Phase 1/2 | 1 |
| Expressive Writing for the Management of Stress in Cancer SurvivorsNCT04776941 · Houston, Texas | Not applicable | 1 |
| Quality of Life, Lifestyle, and Psychosocial Factors in Patients With MelanomaNCT04778449 · Houston, Texas | — | 1 |
| Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH StudyNCT04783168 · Houston, Texas | Not applicable | 1 |
| Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung TrialNCT04789681 · Houston, Texas | Phase 2 | 1 |
| An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment ResponseNCT04796818 · Houston, Texas | Not applicable | 1 |
| Survey of Current Interventional and Diagnostic Imaging Residents After Participation in Endovascular Simulator TrainingNCT04832698 · Houston, Texas | — | 1 |
| Larotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid TumorsNCT04879121 · Houston, Texas | Phase 2 | 1 |
| Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic MalignanciesNCT04888338 · Houston, Texas | — | 1 |
| Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 TherapyNCT04892953 · Houston, Texas | Phase 2 | 1 |
| Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung CancerNCT04913311 · Houston, Texas | — | 1 |
| Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate CancerNCT04947254 · Houston, Texas | Phase 2 | 1 |
| Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open HepatectomyNCT04982653 · Houston, Texas | Phase 2 | 1 |
| Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and EthiopiaNCT04984551 · Houston, Texas | Phase 2 | 1 |
| Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-OncologyNCT04988009 · Houston, Texas | — | 1 |
| Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMNCT04991870 · Houston, Texas | Phase 1 | 1 |
| Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized ChemoradiationNCT05010109 · Houston, Texas | Not applicable | 1 |
| ASTX727, Venetoclax, and Gilteritinib for the Treatment of Newly Diagnosed, Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeNCT05010122 · Houston, Texas | Phase 1/2 | 1 |
| Decitabine Alone or in Combination With Venetoclax, Gilteritinib, Enasidenib, or Ivosidenib as Maintenance Therapy for the Treatment of Acute Myeloid Leukemia in RemissionNCT05010772 · Houston, Texas | Phase 1 | 1 |
| Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic MalignanciesNCT05011045 · Houston, Texas | — | 1 |
| The Impact of COVID-19 on Pulmonary ProceduresNCT05022446 · Houston, Texas | — | 1 |
| Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System MetastasesNCT05026983 · Houston, Texas | Phase 2 | 1 |
| Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)NCT05027633 · Houston, Texas | Phase 2 | 1 |
| A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)NCT05035836 · Houston, Texas | Phase 2 | 1 |
| Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid MalignanciesNCT05039632 · Houston, Texas | Phase 1/2 | 1 |
| IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsNCT05039801 · Houston, Texas | Phase 1 | 1 |
| Hyperpolarized 129-Xenon Imaging in Adult Hematopoietic Cell Transplant Recipients With Pulmonary ImpairmentNCT05041140 · Houston, Texas | — | 1 |
| Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast CancerNCT05042687 · Houston, Texas | Not applicable | 1 |
| Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study)NCT05043012 · Houston, Texas | Not applicable | 1 |
| Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the CervixNCT05046080 · Houston, Texas | — | 1 |
| A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain MetastasesNCT05048212 · Houston, Texas | Phase 2 | 1 |
| Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial CancersNCT05049538 · Houston, Texas | — | 1 |
| PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target IdentificationNCT05049837 · Houston, Texas | — | 1 |
| Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive WomenNCT05053113 · Houston, Texas | Not applicable | 1 |
| High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesNCT05053555 · Houston, Texas | Not applicable | 1 |
| A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer PatientsNCT05053867 · Houston, Texas | Phase 3 | 1 |
| Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit MonitoringNCT05054296 · Houston, Texas | Phase 2 | 1 |
| Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi MethodNCT05054413 · Houston, Texas | — | 1 |
| A Phase 1 With Extension Cohort, Single Arm, Single Center, Open Label Trial of Belantamab Mafodotin for the Treatment of High-Risk Smoldering Multiple MyelomaNCT05055063 · Houston, Texas | Phase 1 | 1 |
| Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance MetricsNCT05056818 · Houston, Texas | — | 1 |
| Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple DischargeNCT05056844 · Houston, Texas | Not applicable | 1 |
| Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking TamoxifenNCT05056857 · Houston, Texas | — | 1 |
| Parenting Support Intervention for Families Coping With Metastatic or Locally Recurrent Solid Tumor DiagnosisNCT05059678 · Houston, Texas | Not applicable | 1 |
| Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain MetastasesNCT05064280 · Houston, Texas | Phase 2 | 1 |
| Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple MyelomaNCT05091372 · Houston, Texas | Phase 2 | 1 |
| Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxNCT05092373 · Houston, Texas | Phase 1 | 1 |
| Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological MalignancesNCT05092451 · Houston, Texas | Phase 1/2 | 1 |
| Hypofractionated Radiation Therapy for Merkel Cell CarcinomaNCT05100095 · Houston, Texas | Phase 2 | 1 |
| Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer PatientsNCT05101213 · Houston, Texas | Phase 1 | 1 |
| Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related TherapiesNCT05108519 · Houston, Texas | — | 1 |
| Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological MalignancesNCT05110742 · Houston, Texas | Phase 1/2 | 1 |
| Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)NCT05123807 · Houston, Texas | Phase 2 | 1 |
| Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingNCT05126810 · Houston, Texas | — | 1 |
| Quality of Life and Function of Patients With Pelvic Tumors After Undergoing HemipelvectomyNCT05134142 · Houston, Texas | — | 1 |
| Quality of Life in Patients With Asymptomatic Monoclonal GammopathiesNCT05136807 · Houston, Texas | — | 1 |
| Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis GuidelinesNCT05143619 · Houston, Texas | — | 1 |
| Molecular Epidemiology of Biliary Tree CancersNCT05179486 · Houston, Texas | — | 1 |
| Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver MetastasesNCT05195710 · Houston, Texas | Phase 1 | 1 |
| First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET ImagingNCT05335811 · Houston, Texas | Phase 1 | 1 |
| Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple MyelomaNCT05336383 · Houston, Texas | Phase 2 | 1 |
| A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the BrainNCT05342454 · Houston, Texas | — | 1 |
| TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant ChemotherapyNCT05343013 · Houston, Texas | Phase 2 | 1 |
| A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's LymphomaNCT05355051 · Houston, Texas | Phase 2 | 1 |
| Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis FungoidesNCT05357794 · Houston, Texas | Phase 2 | 1 |
| A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)NCT05360160 · Houston, Texas | Phase 1/2 | 1 |
| Rice Technologies for Cervical Cancer Screening and DiagnosisNCT05372484 · Houston, Texas | Not applicable | 1 |
| A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast CancerNCT05394259 · Houston, Texas | Phase 1 | 1 |
| Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial CarcinomaNCT05394337 · Houston, Texas | Phase 1/2 | 1 |
| Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast CancerNCT05406232 · Houston, Texas | — | 1 |
| A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch SyndromeNCT05411718 · Houston, Texas | Phase 2 | 1 |
| An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate CancerNCT05454488 · Houston, Texas | Phase 2 | 1 |
| A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell TherapyNCT05464719 · Houston, Texas | Phase 2 | 1 |
| Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced CancerNCT05474846 · Houston, Texas | Phase 2/3 | 1 |
| Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability TestingNCT05497024 · Houston, Texas | — | 1 |
| Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) PatientsNCT05529069 · Houston, Texas | Phase 2 | 1 |
| Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)NCT05536349 · Houston, Texas | Phase 2 | 1 |
| Precision Optical Guidance for Oral BiopsyNCT05554133 · Houston, Texas | Not applicable | 1 |
| A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHLNCT05615636 · Houston, Texas | Phase 2 | 1 |
| A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone SarcomaNCT05621668 · Houston, Texas | Phase 1 | 1 |
| REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)NCT05632809 · Houston, Texas | Phase 2 | 1 |
| Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian CancerNCT05636111 · Houston, Texas | Phase 1 | 1 |
| Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic LeukemiaNCT05645718 · Houston, Texas | Phase 2 | 1 |
| Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.NCT05649072 · Houston, Texas | Not applicable | 1 |
| Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCCNCT05663710 · Houston, Texas | Phase 1/2 | 1 |
| The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense BreastsNCT05667532 · Houston, Texas | Not applicable | 1 |
| A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)NCT05673928 · Houston, Texas | Phase 2 | 1 |
| 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized TrialNCT05674396 · Houston, Texas | Phase 2 | 1 |
| Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United StatesNCT05681026 · Houston, Texas | Not applicable | 1 |
| Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and TelegeneticsNCT05694559 · Houston, Texas | Not applicable | 1 |
| Perceptions of Hospital Care at Home for Patients With Cancer: A Qualitative Study of Cancer Providers, Patients and Caregivers.NCT05694650 · Houston, Texas | — | 1 |
| Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)NCT05700721 · Houston, Texas | Phase 2 | 1 |
| Phase II Study of Nivolumab in Combination With Relatlimab in Patients With Active Melanoma Brain MetastasesNCT05704647 · Houston, Texas | Phase 2 | 1 |
| Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base TumorsNCT05733091 · Houston, Texas | — | 1 |
| Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer SurgeryNCT05766891 · Houston, Texas | Phase 2/3 | 1 |
| A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell LymphomasNCT05773040 · Houston, Texas | Phase 1 | 1 |
| Trial Of PreoperAtive Radiation (TOPAz): A Randomized Trial Comparing Hypofractionated Versus Conventionally Fractionated Preoperative Radiation Followed by Mastectomy With Immediate Autologous Breast Reconstruction With Integrated Nanomechanical Biomarker EvaluationNCT05774678 · Houston, Texas | Phase 3 | 1 |
| Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma PatientsNCT05776979 · Houston, Texas | Phase 2 | 1 |
| Window-of-Opportunity Trial of Ulixertinib for MAPK-Activated GliomasNCT05804227 · Houston, Texas | Early phase 1 | 1 |
| Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial CancerNCT05819892 · Houston, Texas | Phase 1 | 1 |
| A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive DeliriumNCT05837039 · Houston, Texas | — | 1 |
| Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active SurveillanceNCT05840484 · Houston, Texas | — | 1 |
| Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate CancerNCT05873192 · Houston, Texas | Phase 2 | 1 |